These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8731150)

  • 1. Determination of contact phase activation by the measurement of the activity of supernatant and membrane surface-adsorbed factor XII (FXII): its relevance as a useful parameter for the in vitro assessment of haemodialysis membranes.
    Matata BM; Courtney JM; Sundaram S; Wark S; Bowry SK; Vienken J; Lowe GD
    J Biomed Mater Res; 1996 May; 31(1):63-70. PubMed ID: 8731150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro contact phase activation with haemodialysis membranes: role of pharmaceutical agents.
    Matata BM; Wark S; Sundaram S; Courtney JM; Gaylor JD; Bowry SK; Vienken J; Lowe GD
    Biomaterials; 1995 Nov; 16(17):1305-12. PubMed ID: 8573668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive-protein adsorption in contact activation of blood factor XII.
    Zhuo R; Siedlecki CA; Vogler EA
    Biomaterials; 2007 Oct; 28(30):4355-69. PubMed ID: 17644174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolytic properties of activated FXII.
    Braat EA; Dooijewaard G; Rijken DC
    Eur J Biochem; 1999 Aug; 263(3):904-11. PubMed ID: 10469157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of blood purification materials and anticoagulants on the contact activity of factor XI].
    Cheng LP; Sun SD; Yue YL; Huang J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):411-4. PubMed ID: 15931883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
    Mitropoulos KA
    Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of the influence of biomaterials on contact activation.
    Sundaram S; Irvine L; Courtney JM; Lowe GD
    Int J Artif Organs; 1991 Nov; 14(11):729-31. PubMed ID: 1661710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of adsorption, activation, and inhibition of factor XII on immobilized heparin.
    Sanchez J; Elgue G; Riesenfeld J; Olsson P
    Thromb Res; 1998 Jan; 89(1):41-50. PubMed ID: 9610759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of surface-immobilized heparin on the activation of adsorbed factor XII.
    Elgue G; Sanchez J; Egberg N; Olsson P; Riesenfeld J
    Artif Organs; 1993 Aug; 17(8):721-6. PubMed ID: 8215954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor XII truncation accelerates activation in solution.
    de Maat S; Clark CC; Boertien M; Parr N; Sanrattana W; Hofman ZLM; Maas C
    J Thromb Haemost; 2019 Jan; 17(1):183-194. PubMed ID: 30394658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential binding of factor XII and activated factor XII to soluble and immobilized fibronectin--localization of the Hep-1/Fib-1 binding site for activated factor XII.
    Schousboe I; Nystrøm BT; Hansen GH
    FEBS J; 2008 Oct; 275(20):5161-72. PubMed ID: 18793325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymes produced by autoactivation of blood factor XII in buffer: A contribution from the Hematology at Biomaterial Interfaces Research Group.
    Golas A; Pitakjakpipop H; Rahn MS; Siedlecki CA; Vogler EA
    Biomaterials; 2015 Jan; 37():1-12. PubMed ID: 25443791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nanobody-based method for tracking factor XII activation in plasma.
    de Maat S; van Dooremalen S; de Groot PG; Maas C
    Thromb Haemost; 2013 Sep; 110(3):458-68. PubMed ID: 23349032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immobilized transition metal ions stimulate contact activation and drive factor XII-mediated coagulation.
    Mutch NJ; Waters EK; Morrissey JH
    J Thromb Haemost; 2012 Oct; 10(10):2108-15. PubMed ID: 22905925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential-mediated and time-controlled first order activation of factor XII (Hageman factor) adsorbed to carbon surfaces.
    Randriamahazaka HN; Nigretto JM
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):567-73. PubMed ID: 7841313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The second exon-encoded factor XII region is involved in the interaction of factor XII with factor XI and does not contribute to the binding site for negatively charged surfaces.
    Citarella F; Fedele G; Roem D; Fantoni A; Hack CE
    Blood; 1998 Dec; 92(11):4198-206. PubMed ID: 9834224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer.
    Woodruff RS; Xu Y; Layzer J; Wu W; Ogletree ML; Sullenger BA
    J Thromb Haemost; 2013 Jul; 11(7):1364-73. PubMed ID: 23692437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-chain factor XII: a new form of activated factor XII.
    Ivanov I; Matafonov A; Gailani D
    Curr Opin Hematol; 2017 Sep; 24(5):411-418. PubMed ID: 28604413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the histidine-rich glycoprotein domains responsible for contact pathway inhibition.
    Truong TK; Malik RA; Yao X; Fredenburgh JC; Stafford AR; Madarati HM; Kretz CA; Weitz JI
    J Thromb Haemost; 2022 Apr; 20(4):821-832. PubMed ID: 34967109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases.
    Nickel KF; Long AT; Fuchs TA; Butler LM; Renné T
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):13-20. PubMed ID: 27834692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.